Finance

Lists
Q3 2026 earnings • released • EPS beat +16.67% • Revenue miss -0.37%
See results
OSUR:NASDAQ
OraSure Technologies Inc
$3.62
+1.69%
(+0.060) 1D
$3.62
0.00% (0.00)
After hours
Closed: Nov 12, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OSUR...
Open
$3.52
High
$3.67
Low
$3.40
Mkt. cap
249.95M
Avg. vol.
610.60K
Volume
631.10K
52-wk high
$4.58
52-wk low
$2.08
EPS
-$0.69
Beta
1.08
Shares outstanding
69.05M
No. of employees
500
Open
$3.52
High
$3.67
Low
$3.40
Mkt. cap
249.95M
Avg. vol.
610.60K
Volume
631.10K
52-wk high
$4.58
52-wk low
$2.08
EPS
-$0.69
Beta
1.08
Shares outstanding
69.05M
No. of employees
500
News stories
From web sources and news partners
Profile
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test. Wikipedia
About OraSure Technologies Inc
CEOCarrie Eglinton Manner
Employees500
FoundedDec 11, 1987
HeadquartersBethlehem, Pennsylvania, United States
SectorHealth Care
IndustryMedical device
Websiteorasure.com
Analyst ratings
Based on 1 analyst giving stock ratings to OSUR in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for OSUR in the last 3 months
Highest
Current $3.62
$7.00 (+93.37%)
Average
$7.00 (+93.37%)
Lowest
$7.00 (+93.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Bonello
Craig-Hallum
Buy
Initiated
$7.00
+93.4%
10/23/2026
Last report
Nov 10, 2026
Fiscal period
Q3 2026
-$0.15 / -$0.18
+16.67%beat
Revenue / Est. (USD)
30.91M / 31.02M
-0.37%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
26.76M
27.92M
30.64M
30.91M
Cost of goods sold
15.80M
16.06M
17.32M
16.94M
Cost of revenue
15.80M
16.06M
17.32M
16.94M
Research and development expenses
11.42M
13.39M
9.44M
7.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.90M
20.39M
21.03M
18.55M
Operating expense
27.32M
33.78M
30.47M
26.18M
Total operating expenses
43.12M
49.83M
47.79M
43.12M
Operating income
-16.35M
-21.91M
-17.15M
-12.21M
Other non operating income
1.87M
128.00K
272.00K
1.17M
EBT including unusual items
-19.08M
-22.81M
6.30M
-12.39M
EBT excluding unusual items
-15.32M
-21.45M
-16.29M
-11.64M
Income tax expense
210.00K
-432.00K
55.00K
708.00K
Effective tax rate
-1.10%
1.89%
0.87%
-5.72%
Other operating expenses
-
-
-
-
Net income
-19.29M
-22.38M
6.25M
-13.09M
Net profit margin
-72.06%
-80.13%
20.40%
-42.37%
Earnings per share
-0.19
-0.24
-0.20
-0.15
Interest and investment income
-
1.22M
1.20M
-
Interest expense
-
-
-
-
Net interest expenses
-
1.22M
1.20M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.95M
-19.57M
-14.78M
-10.01M
Gain or loss from assets sale
268.00K
-
-20.00K
746.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps